Newsletter | May 9, 2022

05.09.22 -- AAV Development, Manufacturing: Practical, Innovative Solutions

Radiance Label-Free Monitoring Of AAV Transfection In HEK293 Cells

LumaCyte’s Radiance® instrument has the potential to improve the characterization of cell-based AAV transfection and production, improving the efficiency and accuracy of both processes and shortening development time.

Manufacturing Innovation Across New Modalities

The successful outcomes delivered by cell and gene therapies, coupled with the emergence of modalities across nucleic acid therapeutics and microbiomes, poses the next scalability challenge.

Practical, Innovative Solutions For AAV Development, Manufacturing

Explore case studies for neuromuscular degenerative indications, AAV technology and manufacturing, and strategies for navigating the regulatory environments in the U.S. and Europe.

The Journey Into Cell And Gene Therapy

Hear about our venture into the development and manufacturing of viral vector gene therapies and how we are overcoming challenges and maintaining our commitment to our partners.